Recently, a group of researchers under Wyndham Wilson and Kieron Dunleavy, both from NCI, carried out a new study which eliminates the need of radiation therapy while treating Primary Mediastinal B-cell Lymphoma, which is a rare type of cancer.
Presently, the results from this study have been quite encouraging and there is now reason to believe that it may be possible to treat cancer more effectively without making use of radiation in the near future.
Research is an important aspect for finding ways to combat cancer. Many events that are conducted in places like Chicago and Mackinaw in Illinois by Lungevity to fund research and help find better cure.
Although pediatric cancer research is making great strides, a funding shortage threatens further progress in this lifesaving field.
In one groundbreaking trial, researchers injected a young college student’s brain tumor with a form of the polio virus. Because she had previously received the polio vaccine, the girl’s body began to fight the tumor. Once the size of a lime, it’s now the size of a pea.
But scientific breakthroughs can occur only if medical research receives sufficient funding
Next month, Alex’s Lemonade Stand Foundation (ALSF) is teaming up with Northwestern Mutual to host its second Young Investigators Summit and inspire a new generation of pediatric cancer researchers to find treatments and cures in this vastly underfunded field.
“Anybody who can do the math can figure out that kids are getting shortchanged,” said Scott, who believes that cures for most kids can be found within five to ten years.
Nine in ten pediatric cancer researchers say lack of funding is the biggest obstacle to finding a cure,according to a survey by Northwestern Mutual. And nearly a fifth of researchers are considering leaving the field, primarily because of a lack of funds.
“That’s a real eye-opener,” said Scott. “We don’t want to lose a whole generation of potential cancer researchers.”
General practitioners face a dilemma. In a recent survey (Ann Intern Med. 2014;160:11-17), most reported being unfamiliar with the guidelines and uncomfortable treating adult survivors of childhood cancer; however, they can expect to see more such patients each year as treatments for childhood cancer become increasingly successful.
“I envision the development of a subspecialty — either of doctors or nurse practitioners — who deal with cancer patients outside the care of an oncologist and who are trained in survivorship, know a lot about treatment, and know about supportive, palliative, and nutritional care in survivors,” she said.
In the meantime, however, family practitioners are in the driver’s seat.
Dallas researchers have pinpointed a gene that fuels the development of several pediatric cancers, a finding that could serve as an impetus for pharmaceutical companies to develop new cancer treatments that help without using chemotherapy.
For Millions of Teens and Young Adults, Finding a Doctor to Treat Them as They Grow Up Is Hard
“Every youth needs a transition plan to adult care, but for those with complex medical needs who require constant interaction with the health care system, it’s especially important that the connection not be broken,” says GotTransition’s co-director, rheumatologist Patience White.
The debate over compassionate use and “Right to Try” legislation.
The U.S. has a system meant to help: it’s called compassionate use and it’s a way for terminally ill or otherwise optionless patients to access experimental drugs outside of clinical trials. For a patient to receive a medicine on that basis, she must have the support of her physician, the consent of the Food and Drug Administration and a pharmaceutical company willing to supply the drug. That’s where the Trallers, and many others, have gotten stuck.